4D Molecular Therapeutics

IPO

Powering The Future Of Genetic Medicines

Public · Emeryville, United States · Founded 2013 · $165.0M raised

Employees
51–200
Founded
2013
Business Model
B2B
Total Funding
$165.0M
Last Round
$75.0M Series CJun 2020
Rounds
3
Type
Public

About

4D Molecular Therapeutics (4DMT) is a clinical-stage biopharma company inventing genetic medicines using its Therapeutic Vector Evolution platform to create customized AAV vectors for targeted gene delivery. The company focuses on retina and pulmonology indications, including wet AMD, DME, and cystic fibrosis. Founded in 2013, 4DMT is headquartered in Emeryville, California.

Summary

4D Molecular Therapeutics is a Healthcare company based in Emeryville, United States, founded in 2013. It has raised $165.0M in total across 3 rounds, most recently a $75.0M Series C round in Jun 2020. Investors include Viking Global and Versant Ventures.

Tech & App Stack

9 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

IPODec 2020

Sign up to see all 4 rounds

Series A through IPO — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

4D Molecular Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/4d-molecular-therapeutics"><img src="https://indexed.vc/api/badge/company/4d-molecular-therapeutics" alt="4D Molecular Therapeutics on Indexed.vc" width="260" height="76" /></a>